Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Follistatin 344 (1mg)

Alpha BioMed Follistatin 344 (1mg) A provider account is required to view prices and to place orders. Click the button below to submit your application! Have an account? Login here. • Composition and format Follistatin 344 (1 mg) is a recombinant peptide supplied as a lyophilized powder in a single vial. Each vial contains 1 mg of Follistatin 344. The batch-specific Certificate of Analysis (COA) provides protein sequence confirmation, molecular weight verification, and formulation details to support method-level reproducibility and documentation control in research environments. • Analytical verification Each lot is qualified at 95%+ purity by high-performance liquid chromatography; protein identity and structural integrity are confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use. • Intended research use Follistatin 344 is evaluated exclusively in controlled in-vit

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Alpha BioMed

Follistatin 344 (1mg)

A provider account is required to view prices and to place orders. Click the button below to submit your application! Have an account? Login here.

• Composition and format Follistatin 344 (1 mg) is a recombinant peptide supplied as a lyophilized powder in a single vial. Each vial contains 1 mg of Follistatin 344. The batch-specific Certificate of Analysis (COA) provides protein sequence confirmation, molecular weight verification, and formulation details to support method-level reproducibility and documentation control in research environments.

• Analytical verification Each lot is qualified at 95%+ purity by high-performance liquid chromatography; protein identity and structural integrity are confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.

• Intended research use Follistatin 344 is evaluated exclusively in controlled in-vitro systems investigating activin-binding interactions, growth factor signaling pathways, and cellular differentiation models under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.

• Research characteristics and applications Follistatin 344 is characterized by a defined protein structure with high affinity for members of the transforming growth factor-beta (TGF-β) superfamily. In controlled in-vitro environments, researchers employ Follistatin 344 to study ligand-binding dynamics, signaling pathway modulation, and regulatory interactions involving activins and related proteins. Representative applications include assay development, mechanistic pathway investigations, concentration-response analyses, and cellular signaling characterization strictly within laboratory settings.

• Manufacturing and documentation Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. Certificates of Analysis, raw-material sourcing from vetted suppliers, and complete batch documentation are maintained to support institutional procurement review, traceability, and audit readiness.

Research Use Only (RUO) Statement • For in-vitro research only • Not for human or animal consumption • Not for diagnostic or therapeutic use

For licensed research use only. Supplied exclusively to verified healthcare professionals and research institutions. View full details

Connected topics

Follow this recovery question